Ultomiris-exposed Pregnant/ Postpartum
1 clinical trials · Condition
◉ Watch Ultomiris-exposed Pregnant/ Postpartum
| Record | Firm | Date |
|---|---|---|
| Study of Ultomiris® (Ravulizumab) Safety in Pregnancy (NCT06312644) | Alexion Pharmaceuticals, Inc. | 2024-12-16 |
Track Ultomiris-exposed Pregnant/ Postpartum automatically
Every clearance here is in the API, with alerts when new ones post.